UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 319

Sortiert nach

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease

International journal of molecular sciences, 2021-03, Vol.22 (5), p.2761

2021

Volltextzugriff (PDF)

d-glutamate and Gut Microbiota in Alzheimer's Disease

International journal of molecular sciences, 2020-04, Vol.21 (8), p.2676

2020

Volltextzugriff (PDF)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review

International journal of molecular sciences, 2021-07, Vol.22 (15), p.8208

2021

Volltextzugriff (PDF)

Machine learning and systems genomics approaches for multi-omics data

Biomarker research, 2017-01, Vol.5 (1), p.2-2, Article 2

2017

Volltextzugriff (PDF)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions

Scientific reports, 2021-03, Vol.11 (1), p.6922-6922, Article 6922

2021

Volltextzugriff (PDF)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches

International journal of molecular sciences, 2020-02, Vol.21 (3), p.969

2020

Volltextzugriff (PDF)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease

International journal of molecular sciences, 2021-02, Vol.22 (5), p.2283

2021

Volltextzugriff (PDF)

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2146

2021

Volltextzugriff (PDF)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection

Scientific reports, 2021-05, Vol.11 (1), p.10179-10179, Article 10179

2021

Volltextzugriff (PDF)

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

Molecules (Basel, Switzerland), 2020-07, Vol.25 (14), p.3250

2020

Volltextzugriff (PDF)

Brain Stimulation in Alzheimer's Disease

Frontiers in psychiatry, 2018-05, Vol.9, p.201-201

2018

Volltextzugriff (PDF)

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease

Psychiatry and clinical neurosciences, 2023-02, Vol.77 (2), p.102-109

2023

Volltextzugriff (PDF)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease

International journal of molecular sciences, 2021-08, Vol.22 (15), p.7911

2021

Volltextzugriff (PDF)

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

Scientific reports, 2017-11, Vol.7 (1), p.14849-10, Article 14849

2017

Volltextzugriff (PDF)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress

Frontiers in psychiatry, 2019-02, Vol.10, p.93

2019

Volltextzugriff (PDF)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9718

2021

Volltextzugriff (PDF)

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy

International journal of molecular sciences, 2021-08, Vol.22 (16), p.8654

2021

Volltextzugriff (PDF)

The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia

Frontiers in pharmacology, 2019-05, Vol.10, p.540-540

2019

Volltextzugriff (PDF)

Molecular Basis of Late-Life Depression

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7421

2021

Volltextzugriff (PDF)

Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia

Schizophrenia research, 2013-05, Vol.146 (1), p.231-237

2013

Volltextzugriff (PDF)

Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches

Journal of psychopharmacology (Oxford), 2021-03, Vol.35 (3), p.265-272

2021

Volltextzugriff (PDF)

An Investigation into Smartphone Addiction with Personality and Sleep Quality among University Students

International journal of environmental research and public health, 2021-07, Vol.18 (14), p.7588

2021

Volltextzugriff (PDF)

Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant

Current drug targets, 2020-01, Vol.21 (6), p.610

2020

Volltextzugriff (PDF)

Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

Biological psychiatry (1969), 2014-05, Vol.75 (9), p.678-685

2014

Volltextzugriff (PDF)

d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia

International journal of molecular sciences, 2021-10, Vol.22 (20), p.10917

2021

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(256)
Life Sciences & Biomedicine
(244)
Humans
(184)
Psychiatry
(142)
Male
(129)
Female
(125)
Adult
(120)
Middle Aged
(89)
Schizophrenia
(87)
Pharmacology & Pharmacy
(82)
Neurosciences & Neurology
(72)
Neurosciences
(61)
Biological And Medical Sciences
(59)
Medical Sciences
(59)
Schizophrenia - Drug Therapy
(57)
Psychology. Psychoanalysis. Psychiatry
(50)
Antipsychotic Agents - Therapeutic Use
(44)
Clinical Neurology
(42)
Treatment Outcome
(38)
Aged
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease

d-glutamate and Gut Microbiota in Alzheimer's Disease

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review

Machine learning and systems genomics approaches for multi-omics data

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

Brain Stimulation in Alzheimer's Disease

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy

The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia

Molecular Basis of Late-Life Depression

Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia

Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches

An Investigation into Smartphone Addiction with Personality and Sleep Quality among University Students

Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant

Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia

Suchergebnisse filtern